Correlation Between Pharvaris and AstraZeneca PLC
Can any of the company-specific risk be diversified away by investing in both Pharvaris and AstraZeneca PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and AstraZeneca PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharvaris BV and AstraZeneca PLC ADR, you can compare the effects of market volatilities on Pharvaris and AstraZeneca PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of AstraZeneca PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and AstraZeneca PLC.
Diversification Opportunities for Pharvaris and AstraZeneca PLC
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Pharvaris and AstraZeneca is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and AstraZeneca PLC ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AstraZeneca PLC ADR and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with AstraZeneca PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AstraZeneca PLC ADR has no effect on the direction of Pharvaris i.e., Pharvaris and AstraZeneca PLC go up and down completely randomly.
Pair Corralation between Pharvaris and AstraZeneca PLC
Given the investment horizon of 90 days Pharvaris BV is expected to generate 2.21 times more return on investment than AstraZeneca PLC. However, Pharvaris is 2.21 times more volatile than AstraZeneca PLC ADR. It trades about -0.04 of its potential returns per unit of risk. AstraZeneca PLC ADR is currently generating about -0.22 per unit of risk. If you would invest 2,375 in Pharvaris BV on August 30, 2024 and sell it today you would lose (139.00) from holding Pharvaris BV or give up 5.85% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
Pharvaris BV vs. AstraZeneca PLC ADR
Performance |
| Timeline |
| Pharvaris BV |
| AstraZeneca PLC ADR |
Pharvaris and AstraZeneca PLC Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pharvaris and AstraZeneca PLC
The main advantage of trading using opposite Pharvaris and AstraZeneca PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, AstraZeneca PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will offset losses from the drop in AstraZeneca PLC's long position.| Pharvaris vs. Ikena Oncology | Pharvaris vs. Eliem Therapeutics | Pharvaris vs. HCW Biologics | Pharvaris vs. RenovoRx |
| AstraZeneca PLC vs. Novartis AG ADR | AstraZeneca PLC vs. GlaxoSmithKline PLC ADR | AstraZeneca PLC vs. Roche Holding Ltd | AstraZeneca PLC vs. Bristol Myers Squibb |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |